Patent Assignment
Reel/Frame 069831/0501
Security Interest
Recorded: 2024-12-31
Pages: 71
Assignee
KENSINGTON CLENE 2024 LLC
6550 SOUTH MILLROCK DRIVE, SALT LAKE CITY, UTAH, 84121
Covered Properties
(22)
Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor
Application:
17/223,336 →
Publication:
US 2021/0236542
Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor
Application:
17/229,013 →
Publication:
US 2021/0361699
Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom
Continuous, Semicontinuous and Batch Methods for Treating Liquids and Manufacturing Certain Constituents (E.G.,Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(S) and Colloids Resulting Therefrom
Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor
Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor
Continuous, Semicontinuous and Batch Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) and Colloids Resulting Therefrom
Continuous, Semicontinuous and Batch Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) and Colloids Resulting Therefrom
Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor
Novel Gold-Platinum Based Bi-Metallic Nanocrystal Suspensions, Electrochemical Manufacturing Processes Therefor and Uses for the Same
Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom
Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom
Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom
Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom
Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (E.G., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(S) Resulting Therefrom
Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle /Liquid Solution(s) Therefrom
Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom
Continuous Semicontinuous and Batch Methods for Treating Liquids and Manufacturing Certain Constituents (E.G., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(S) and Colloids Resulting Therefrom
PCT:
PCT/US2010/000088 ↗
Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor
PCT:
PCT/US2010/041427 ↗
Novel Gold-Platinum Based Bi-Metallic Nanocrystal Suspensions, Electrochemical Manufacturing Processes Therefor and Uses for the Same
PCT:
PCT/US2012/031654 ↗
Methods and Treatment for Certain Demyelination and Dysmyelination-Based Disorders and/or Promoting Remyelination.
PCT:
PCT/US2014/037280 ↗
Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (E.G., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(S) Resulting Therefrom
PCT:
PCT/US2008/008558 ↗
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Nunc Pro Tunc Assignment
Jul 1, 2014
From: PIERCE, DAVID KYLE; MORTENSON, MARK GORDON; BRYCE, DAVID ANDREW; DORFMAN, ADAM ROBERT
To: GR INTELLECTUAL RESERVE, LLC
Reel/Frame 033264/0357 →
Nunc Pro Tunc Assignment
Jul 9, 2014
From: PIERCE, DAVID KYLE; MORTENSON, MARK G.; BRYCE, DAVID A.
To: GR INTELLECTUAL RESERVE, LLC
Reel/Frame 033273/0741 →
Nunc Pro Tunc Assignment
Jul 12, 2016
From: PIERCE, DAVID KYLE; MORTENSON, MARK GORDON; BRYCE, DAVID ANDREW; DORFMAN, ADAM ROBERT
To: GR INTELLECTUAL RESERVE, LLC
Reel/Frame 039315/0087 →
Nunc Pro Tunc Assignment
Jul 22, 2016
From: PIERCE, DAVID KYLE, MR.; MORTENSON, MARK G., MR.; BRYCE, DAVID A., MR.
To: GR INTELLECTUAL RESERVE, LLC
Reel/Frame 039218/0602 →
Nunc Pro Tunc Assignment
Aug 10, 2016
From: PIERCE, DAVID K., MR.; MORTENSON, MARK G., MR.; BRYCE, DAVID A., MR.
To: GR INTELLECTUAL RESERVE, LLC
Reel/Frame 039396/0878 →
Nunc Pro Tunc Assignment
Aug 10, 2016
From: PIERCE, DAVID KYLE, MR.; MORTENSON, MARK G., MR.; BRYCE, DAVID A., MR.
To: GR INTELLECTUAL RESERVE, LLC
Reel/Frame 039395/0576 →
Assignment of Assignor's Interest
Jan 23, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041043/0865 →
Assignment of Assignor's Interest
Feb 1, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041147/0923 →
Assignment of Assignor's Interest
Feb 1, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041148/0013 →
Assignment of Assignor's Interest
Feb 1, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041148/0103 →
Assignment of Assignor's Interest
Feb 1, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041148/0736 →
Assignment of Assignor's Interest
Feb 1, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041588/0655 →
Assignment of Assignor's Interest
Feb 1, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041146/0612 →
Assignment of Assignor's Interest
Feb 1, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041147/0527 →
Assignment of Assignor's Interest
Feb 1, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041147/0820 →
Assignment of Assignor's Interest
Feb 24, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 041811/0288 →
Assignment of Assignor's Interest
Sep 18, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 043889/0220 →
Assignment of Assignor's Interest
Jul 17, 2018
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 046370/0920 →
Assignment of Assignor's Interest
Jul 17, 2018
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 046371/0537 →
Nunc Pro Tunc Assignment
Aug 31, 2018
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 046770/0621 →
Nunc Pro Tunc Assignment
Aug 31, 2018
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 046770/0237 →
Assignment of Assignor's Interest
Aug 8, 2019
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 050007/0937 →
Assignment of Assignor's Interest
Nov 3, 2025
From: KAVANAGH, KYLE DENNIS
To: CHICAGO MERCANTILE EXCHANGE INC.
Reel/Frame 072757/0782 →